AsepticSure Hospital Disinfection System Expands North American Patent Coverage

San Francisco, California, December 12, 2016 – Medizone International, Inc. (The Company) (OTCQB:MZEI)  Following its recently announced EPA approval to enter the US market with its WHO Award winning and peer reviewed AsepticSure® Hospital Disinfection Technology,  the Company today announces Mexico has agreed to grant  a patent for its HEALTHCARE FACILITY DISINFECTING PROCESS AND SYSTEM WITH OXYGEN/OZONE MIXTURE.  This patent essentially conformed with the claims to those previously granted for the European Union. Countries that have now granted coverage for this revolutionary hospital disinfection technology include Canada, the United States, Mexico, China, Singapore, The United Kingdom, France and Germany with additional applications pending and processing.

Additional patent grants for BIO-TERRORISM COUNTERACTION USING OZONE AND HYDROGEN PEROXIDE have been granted by the United States, The United Kingdom, France and Germany.

A patent covering SPORTS EQUIPMENT AND FACILITY DISINFECTION has been granted in the United States and a Notice of Allowance received for Canada.

This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.


For press information on Medizone International, please contact:

John Pentony, Investor and Media Relations
Medizone International, Inc.
T: 01 415 331-0202
E: [email protected]

For more information, visit:
Email: [email protected]


Medizone International, Inc. (OTCQB: MZEI)

350 East Michigan Avenue – Suite 500
Kalamazoo, MI 49007

Telephone: (269) 202-5020

Email: [email protected]

Media and Investor Relations:

John Pentony

Medizone International, Inc.

Telephone: (269) 202-5020

Email: [email protected]

Social Media